Oncology/Hematology

Myeloma

More in Myeloma

WHO Links Sweetener to Cancer; Younger-Age CRC Risk; PCOS and Ovarian Cancer

News, features, and commentary about cancer-related issues

Jun 29, 2023
Onco Break over a computer rendering of a cancer cell.
'Redlining' and Cancer Screening; Talzenna OK'd for mCRPC; Genomic Testing Misused

News, features, and commentary about cancer-related issues

Jun 22, 2023
Onco Break over a computer rendering of a cancer cell.
New Agents for Relapsed/Refractory Myeloma Impress in Early-Stage Clinical Trials

High rates of deep, durable response with bispecific antibody, rapidly produced CAR T-cell agents

Jun 05, 2023
ASCO over a photo of McCormick place in Chicago, IL.
CAR-T Tops Standard Care in Heavily Pretreated Lenalidomide-Refractory Myeloma

Ciltacabtagene autoleucel improved progression-free survival versus two standard triplets

Jun 05, 2023
ASCO over a photo of McCormick place in Chicago, IL.
World's Smallest Skin Cancer; Exercise Boosts Immune Cells; Cannabis and Pain Relief

News, features, and commentary about cancer-related issues

May 05, 2023
Onco Break over a computer rendering of a cancer cell.
Blood, Breast Cancer Survivors Stand Out for Heart Risks Over a Decade Later

Research suggests cancer-specific precision monitoring and risk stratification

Apr 19, 2023
A photo of a mature woman holding a pink breast cancer ribbon.
Novel Antibody Induces Durable Responses in Heavily Pretreated Myeloma

Overall response rate of 90% in patients who received highest doses of REGN5459

Apr 18, 2023
AACR over a photo of Orange County Convention Center in Orlando, Florida.
CAR-T Makes Its Case for Earlier Use in Multiple Myeloma

Ide-cel tripled median PFS versus standard regimens in phase III study

Feb 10, 2023
A computer rendering of CAR T-cells attacking a cancer cell.
Novel 'Off the Shelf' CAR-T Product Shows Promise in Myeloma

Researchers say safety, efficacy of ALLO-715 comparable to autologous anti-BCMA products

Feb 02, 2023
A computer rendering of CAR T-cell immunotherapy.
ODAC to Review Lymphoma Drug; Tobacco Control; Artificial Skin Aids Cancer Studies

News, features, and commentary about cancer-related issues

Jan 27, 2023
Onco Break over a computer rendering of a cancer cell.
Post-Transplant Triplet Bests Lenalidomide Maintenance Alone in Myeloma

Longer PFS with carfilzomib, lenalidomide, and dexamethasone, interim analysis shows

Jan 17, 2023
A micrograph of multiple myeloma cells.
Off-the-Shelf T-Cell Therapy Effective Against Viral Infections After Allo-HCT

Produced an antiviral response in 95% of patients with six different types of infection

Jan 13, 2023
A computer rendering of T-cells attacking viruses
Cancer Survivors Say No to HPV Vax; Costly Prostate Cancer; Acupressure Aids Sleep

News, features, and commentary about cancer-related issues

Dec 29, 2022
Onco Break over a computer rendering of a cancer cell.
Upfront Transplant Prevails Again in Newly Diagnosed Myeloma

But U.K. trial suggests MRD assessment after induction could potentially help guide treatment

Dec 20, 2022
A photo of a bag of hematopoietic stem cells
More in Myeloma

Continuing Medical Education

0.50 CME Credits
Integrating Novel Classes of Immunotherapy Into Treatment Paradigms in Advanced/Metastatic Melanoma

0.50 CME Credits
Expert Strategies to Monitor and Mitigate Adverse Events During Breast Cancer Treatment

0.50 CME Credits
Clinical Case Challenge: Applying the Latest Evidence to Improve Outcomes in BRAF Mutant Advanced Melanoma

0.50 CME Credits
Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes

1.00 CME Credits
Expert Perspectives in Managing Lower-Risk Myelodysplastic Syndromes

0.50 CME Credits
Integrating the Latest Evidence into Patient-Centered Treatment for Advanced/Metastatic Triple Negative Breast Cancer

0.50 CME Credits
Evidence-Based Strategies to Improve Outcomes for Patients With Gastroesophageal Cancers

1.00 CME Credits
Incorporating Recent Data Into Current Treatment Paradigms in Melanoma